Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Methotrexate Well Tolerated, Effective for Psoriasis in Chinese
THURSDAY, Jan. 31, 2019 (HealthDay News) — Methotrexate is well tolerated and effective for psoriasis in a Chinese population and is more effective for those without psoriatic arthritis, according to a study published online Jan. 30 in JAMA Dermatology.
Off-Label Uses in Dermatology Often Missing From Compendia
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The compendia used by Medicare for making coverage determinations are inadequate for dermatologic illnesses, and there is considerable discrepancy between compendia, according to a study published online Jan. 23 in JAMA Dermatology.
Washington State Declares Health Emergency as Measles Spreads
MONDAY, Jan. 28, 2019 (HealthDay News) — A statewide public health emergency was declared in Washington after a measles outbreak near Portland, Oregon, reached 31 cases on Friday. The outbreak in the Pacific Northwest is in what has been called an antivaccination “hot spot” in the United States, the Associated Press reported.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
Measles Outbreak Prompts Public Emergency in Washington State
THURSDAY, Jan. 24, 2019 (HealthDay News) — An ongoing measles outbreak has led to a public health emergency being declared in Clark County, Washington.
Guidelines Developed for Managing Severe Atopic Dermatitis
TUESDAY, Jan. 22, 2019 (HealthDay News) — Guidelines have been developed for the management of severe atopic dermatitis (AD); the recommendations have been published as a clinical management review in the January issue of The Journal of Allergy and Clinical Immunology: In Practice.
Wait Times Have Improved in VA Health Care System
FRIDAY, Jan. 18, 2019 (HealthDay News) — From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs (VA) health care system, resulting in reduced wait times versus the private sector (PS) in 2017, according to a study published online Jan. 18 in JAMA Network Open.
Melanoma Survival Varies Among U.S. States